DOJ asks court for final approval of CVS-Aetna deal

The Department of Justice has asked a judge to approve the $69 billion merger between CVS Health and Aetna, which was closed by the two companies at the end of 2018, Reuters reported. The deal has been hung up on court approval, though it has been approved by all other regulators and the DOJ.

As the deal was set to close, Judge Richard Leon of the U.S. District Court for the District of Columbia noted that the government appeared to have given the transaction a “rubber stamped” approval and voiced antitrust concerns.

At this point, Leon could approve the deal or hold a hearing to bring voice to critics of the deal, Reuters reported.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.